How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?
ContributorsMetral, M; Nadin, I; Locatelli, I; Tarr, P E; Calmy, Alexandra ; Kovari, H; Brugger, P; Cusini, A; Gutbrod, K; Schmid, P; Schwind, M; Kunze, U; Di Benedetto, C; Pignatti, R; Du Pasquier, R; Darling, Kea ; Cavassini, M; Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study group; Swiss HIV Cohort Study
Published inHIV medicine, vol. 21, no. 5, p. 342-348
Publication date2020-05
First online date2019-12-27
Abstract
Keywords
- HIV and aging
- Neurocognitive impairment
- Neuropsychological testing
- Predictive values
- Screening
- Cognitive Aging
- Cognitive Dysfunction / diagnosis
- Cognitive Dysfunction / etiology
- Europe
- Female
- HIV Infections / psychology
- Humans
- Longitudinal Studies
- Male
- Mental Status and Dementia Tests
- Middle Aged
- Prospective Studies
- Societies, Medical
- Surveys and Questionnaires
Affiliation
Research group
Citation (ISO format)
METRAL, M et al. How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population? In: HIV medicine, 2020, vol. 21, n° 5, p. 342–348. doi: 10.1111/hiv.12828
Main files (1)
Article (Published version)
Secondary files (3)
Identifiers
- PID : unige:173136
- DOI : 10.1111/hiv.12828
- PMID : 31883203
- PMCID : PMC7216878
Commercial URLhttps://onlinelibrary.wiley.com/doi/10.1111/hiv.12828
ISSN of the journal1464-2662